Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing-Remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04688788
What this trial is testing

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Rigshospitalet, Denmark 600
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Testing effectiveness (Phase 2)Study completedNCT01450124
What this trial is testing

Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Universitätsklinikum Hamburg-Eppendorf 29
Not applicableStudy completedNCT02010554
What this trial is testing

Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS

Who this might be right for
Relapsing-remitting Multiple Sclerosis
University of Missouri, Kansas City 40
Not applicableStudy completedNCT05423769
What this trial is testing

Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Hikma Pharmaceuticals LLC 30
Not applicableStudy completedNCT01881191
What this trial is testing

Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months

Who this might be right for
Multiple Sclerosis
University at Buffalo 50
Not applicableActive Not RecruitingNCT07497126
What this trial is testing

The Prevalance of Malnutrition and Its Association With Disability in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Malnutrition or Risk of Malnutrition
Antalya Training and Research Hospital 169
Not applicableNot Yet RecruitingNCT07827586
What this trial is testing

Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Hoffmann-La Roche 1,800
Large-scale testing (Phase 3)WithdrawnNCT00429442
What this trial is testing

Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Anna Tsakiri
Not applicableStudy completedNCT04833673
What this trial is testing

The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingPain, ChronicFatigue Syndrome, Chronic+1 more
Hacettepe University 80
Testing effectiveness (Phase 2)Temporarily pausedNCT04909502
What this trial is testing

Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Emerald Health Pharmaceuticals 50
Post-approval studies (Phase 4)Study completedNCT01623596
What this trial is testing

Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 881
Testing effectiveness (Phase 2)Study completedNCT00525668
What this trial is testing

Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Charite University, Berlin, Germany 120
Not applicableStudy completedNCT01075880
What this trial is testing

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 300
Early research (Phase 1)Study completedNCT02193217
What this trial is testing

Explore the Cardiac Pharmacodynamics of MT-1303

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Tanabe Pharma Corporation 81
Not applicableUnknownNCT04857489
What this trial is testing

Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapse Remitting Multiple Sclerosis
Thomas Jefferson University 80
Not applicableStudy completedNCT04756687
What this trial is testing

Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Biogen 1,507
Not applicableUnknownNCT06516458
What this trial is testing

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis Relapse+1 more
Shirley Ryan AbilityLab 40
Testing effectiveness (Phase 2)Study completedNCT01717664
What this trial is testing

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
RedHill Biopharma Limited 18
Not applicableUnknownNCT04380220
What this trial is testing

Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple SclerosisRelapse
Regina Elena Cancer Institute 80
Next Page